C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting - Wikidata - wikimedia - TriplyDB

C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting

C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting

http://www.wikidata.org/entity/Q35422257

about

Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Cachectic skeletal muscle response to a novel bout of low-frequency stimulation Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1 Catabolic signaling pathways, atrogenes, and ubiquitinated proteins are regulated by the nutritional status in the muscle of the fine flounder.PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting C26 cancer-induced muscle wasting is IKKβ-dependent and NF-kappaB-independent.Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia.A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.Acetylation and deacetylation--novel factors in muscle wasting.Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.Differential expression of HDAC and HAT genes in atrophying skeletal muscle.p38β MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBPβ.CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2.An acetylation rheostat for the control of muscle energy homeostasis Leucine-rich diet supplementation modulates foetal muscle protein metabolism impaired by Walker-256 tumour.Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.Activin A induces skeletal muscle catabolism via p38β mitogen-activated protein kinase.Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90.Modeling human cancer cachexia in colon 26 tumor-bearing adult mice.Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture.Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis.Skeletal Muscle Function During the Progression of Cancer Cachexia in the Male ApcMin/+ Mouse.TAK1 regulates skeletal muscle mass and mitochondrial function.The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease.Impact of denervation-induced muscle atrophy on housekeeping gene expression in mice.Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice

P2860

Q27334169-621F4F46-D611-4331-9F53-24AEF2A0D335 Q28606560-5EA04CA2-5A8D-44C4-8ACD-B2A07DD99D67 Q30384810-232045B0-DA7E-4DFF-B248-4E0CCC88A11C Q33673314-334ACC95-A012-4A07-9533-2A3E2D786281 Q33720208-438D56EF-1990-486A-9680-75F1EDF92202 Q34200869-86251B3C-2CB1-40FD-B10C-5F05F03C3AC5 Q34424991-EBBBF9E5-0D46-4D87-A2F9-7C501C3E13BC Q34652034-947288B1-880E-48F9-9A2E-DF1BFC09F6F4 Q35086723-40B9B0A8-A802-4027-B52A-A3C01255448D Q35341311-4DBFC0F4-131A-4DF6-A83D-5D8A6F7469CA Q35536351-5E3C435D-1EDF-4303-B2E3-08705EE74A51 Q35545361-FFD3EB80-5575-45DF-846E-76B3F553E1BA Q35925919-E1C11843-0851-41CA-B06E-75CE086BEBE4 Q36176015-C26186AE-1486-4E5B-97F6-14E704502721 Q36198934-4E22AAF0-A550-482A-AF29-5D1056A73105 Q36422693-8F384F50-D13A-45DC-B121-EF469C7D390A Q36469975-1CD2AEB1-ADD1-4C4E-9E5E-0CD3A10EE92A Q36500673-62574DAE-6F61-4659-839D-2EFE05118262 Q36514936-3544A176-48BB-465A-AF58-C2D18904DCC2 Q36901945-07B2B963-78B4-4A8D-9E87-0C42428266F2 Q36945094-0DACAEC4-96B2-41EE-84B4-3D1D853F9D41 Q37351106-DBCB35AD-76DB-4747-A4A7-9DE6CD7E5FE3 Q37493688-B58FA1C9-CAFF-4C7D-BDAF-E450A04CB8CA Q37503704-383C8443-F6CC-46C6-A9F7-443554BEE103 Q37536603-426CA99A-675B-4820-BB99-BE1AC1D90BBF Q37734795-EAFE3742-9FF5-439A-9840-9820F9B1168D Q40956876-102D6688-68D0-44F0-A54D-BDBACAD9A107 Q40972142-443DAE38-0C41-461D-A2A4-297B4CD945CC Q41701219-62A5D81A-C905-4EBD-B4D1-C8CF0FACE79B Q42229082-26ED7368-E303-4CA3-93DF-109F9065E6D3 Q42367875-CDC1FB8F-E086-4F2B-B894-7A9E198C0645 Q47233582-8F76077A-EE60-41C2-90DF-D27015977E2C Q47419257-B6B4BCF6-4268-455C-BEC1-88DF2DA19D4D Q50130561-FDFBAA87-B3E1-4FCF-B1BA-D0E3E242ECC7 Q51000404-1345384A-4422-463E-BBB4-D0B6692344BA Q54204358-44A4588C-6534-43A4-9695-F884118E87D4 Q57458063-33CD96A9-43FA-4BDB-A59F-A7F026DDA018

P2860

C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting

http://www.wikidata.org/entity/Q35422257

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@ast

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@en

type

label

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@ast

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@en

prefLabel

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@ast

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@en

P1433

Q35422257-E8EAE335-E25E-4D52-B9C2-340AD25B431B

P1476

Q35422257-6E88F3D4-2FB8-4F40-A532-31094771D719

P2093

Q35422257-3386E073-3DA2-44E3-BD57-2FF77DEF5DB2

Q35422257-40225184-DD0E-4EF8-8702-1115B9123A61

Q35422257-A5F6E01B-2424-46C4-8FD3-5F5BE9A519C8

P2860

Q35422257-0402B2B7-B6FA-4AF5-8DE5-8908FC9FFD42

Q35422257-0B04F362-0948-4480-96BF-61D65E94A29D

Q35422257-0C92AA37-CD85-4524-B17E-6E67E1686367

Q35422257-12788EE3-35A9-462E-8A37-F80BED6D1C17

Q35422257-129581EF-7F91-463D-BFA0-096131903742

Q35422257-12AD67B8-8907-4982-B378-7582CAC82A1A

Q35422257-13BE6462-7B77-4EBB-933F-E27E5EC25C06

Q35422257-1ACAC60C-D7FD-4C74-887E-58DA6E34E67A

Q35422257-1DD2B21D-9D8C-4251-9A76-0C58E2DCCC63

Q35422257-1E89D498-7F2B-4E0C-B6D7-5F911973B416

P304

Q35422257-48D4B28B-361D-4C82-8689-414170B7436D

P31

Q35422257-E33FE0FF-D78F-4CD1-A55A-539BDDE1ED04

P356

Q35422257-676F8FF9-4818-4ABA-8EB4-A3017B2155A8

P407

Q35422257-E5B536A7-297F-47ED-B577-08A458DB9A94

P433

Q35422257-43E78F50-A67A-488F-913D-8772D80379CC

P478

Q35422257-278F52DF-930F-40EF-AE6F-447AF760C274

P577

Q35422257-B0E35BDC-4FB9-4C70-9239-DCDD96C3A15A

P5875

Q35422257-B6B2356A-CB22-47D1-9402-842C0D0347F1

P698

Q35422257-BE73C2FD-FA37-4F4E-B7C0-5016B9625B0F

P932

Q35422257-E32C1012-57F3-410D-96C7-81B78A17F707

P356

P1433

The EMBO Journal

P1476

C/EBPβ mediates tumour-induced ...... pregulation and muscle wasting

@en

P2093

Bingwen Jin

http://www.w3.org/2001/XMLSchema#string

Guohua Zhang

http://www.w3.org/2001/XMLSchema#string

Yi-Ping Li

http://www.w3.org/2001/XMLSchema#string

P2860

CCAAT/enhancer-binding proteins: structure, function and regulation

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states

An essential role for C/EBPbeta in female reproduction

Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo

C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

Identification of ubiquitin ligases required for skeletal muscle atrophy

Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

P304

4323-4335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMBOJ.2011.292

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51576516

http://www.w3.org/2001/XMLSchema#string

P698

21847090

http://www.w3.org/2001/XMLSchema#string

P932

3199382

http://www.w3.org/2001/XMLSchema#string